Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation

Haemophilus influenzae type b conjugate vaccine.

Safety review results of Pneumococcal conjugate vaccine and Haemophilus influenzae type b(Hib) vaccine for pediatrics

Seven fatal cases have been reported in infants who simultaneously received multiple vaccinations including pediatric pneumococcal conjugate vaccine and Hib vaccine since March 2 2011.The joint meeting evaluated those cases based on the detailed information which was newly obtained from autopsy reports, medical records etc. on their courses and severities of the illnesses of these cases, includ...

Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.

AIMS To compare the convalescent antibody response to invasive Haemophilus influenzae type b (Hib) disease between conjugate vaccine immunised and unimmunised children, to look for evidence of priming for immunologic memory. METHODS Unmatched case-control study in the UK and Eire 1992-2001 and Victoria, Australia 1988-1990. A total of 93 children were identified as having invasive Hib disease...

Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.

CONTEXT Haemophilus influenzae type b (Hib) conjugate vaccine is not perceived as a public health priority in Africa because data on Hib disease burden and vaccine effectiveness are scarce. Hib immunization was introduced in Kenyan infants in 2001. OBJECTIVE To define invasive Hib disease incidence and Hib vaccine program effectiveness in Kenya. DESIGN, SETTING, AND PATIENTS Culture-based s...

Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi

A retrospective database review showed that Haemophilus influenzae type b conjugate vaccine decreased the annual number of cases of H. influenzae type b meningitis in children in Blantyre, Malawi. Among young bacterial meningitis patients, HIV prevalence was high (36.7% during 1997-2009), and pneumococcus was the most common etiologic agent (57% in 2009).